Späh F
Cardiovasc Res. 1986 Jan;20(1):42-51. doi: 10.1093/cvr/20.1.42.
In isolated electrically stimulated guinea pig papillary muscles tiapamil exerts a negative inotropic action that corresponds to its presumptive inhibitory effects on the slow-channel-mediated transmembrane Ca2+ influx. However, contractile depression is always accompanied by marked alterations of the normal Na+-carried action potential. Thus Na+-dependent upstroke velocity (dV/dtmax) declines while the length of the plateau phase increases. These observations indicate that tiapamil, besides inhibiting Ca2+ inflow, also interferes with the fast inward Na+ current and possibly also reduces the repolarising K+ efflux. After partial depolarisation with a K+-rich tyrode solution (19 mmol X litre-1 K+). tiapamil lowers the Ca2+-dependent contractile force as it reduces the bioelectric parameters (upstroke velocity, amplitude, duration) of the Ca2+-mediated action potentials. Moreover, in partially depolarised myocardium, the Mg2+-induced bioelectric membrane activity is suppressed by tiapamil. Tiapamil probably operates as an agent with mixed Na+-, K+-, Ca2+- and Mg2+-antagonistic effects and, in this respect, differs considerably from the more specific Ca2+ antagonists such as verapamil, D 600 (gallopamil), nifedipine (and other 1,4-dihydropyridines) or diltiazem. However, tiapamil by virtue of its combined damping actions on both transmembrane Na+ and Ca2+ conductivities (together with prolongation of the action potential plateau), is a drug which exerts, simultaneously, the fundamental myocardial membrane effects of antiarrhythmic agents of group I, III and IV, according to the classification of Singh and Vaughan Williams. Thus these bioelectrical observations are in accordance with the results of clinical studies on tiapamil, which have demonstrated directly its antiarrhythmic efficacy.
在分离的电刺激豚鼠乳头肌中,噻帕米可产生负性肌力作用,这与其对慢通道介导的跨膜Ca2+内流的推测性抑制作用相符。然而,收缩力降低总是伴随着正常钠携带动作电位的显著改变。因此,钠依赖性上升速度(dV/dtmax)下降,而平台期长度增加。这些观察结果表明,噻帕米除了抑制Ca2+内流外,还干扰快速内向钠电流,并且可能还减少复极化钾外流。在用富含钾的台氏液(19 mmol·L-1 K+)进行部分去极化后,噻帕米降低了钙依赖性收缩力,因为它降低了钙介导动作电位的生物电参数(上升速度、幅度、持续时间)。此外,在部分去极化的心肌中,噻帕米抑制镁诱导的生物电膜活性。噻帕米可能作为一种具有混合的钠、钾、钙和镁拮抗作用的药物,在这方面,它与更特异性的钙拮抗剂如维拉帕米、D 600(加洛帕米)、硝苯地平(和其他1,4-二氢吡啶类)或地尔硫卓有很大不同。然而,噻帕米凭借其对跨膜钠和钙电导率的联合抑制作用(以及动作电位平台期的延长),是一种根据辛格和沃恩·威廉姆斯分类同时发挥I、III和IV类抗心律失常药物基本心肌膜效应的药物。因此,这些生物电观察结果与关于噻帕米的临床研究结果一致,这些研究直接证明了其抗心律失常疗效。